KYMR
Price
$107.39
Change
-$2.73 (-2.48%)
Updated
Oct 2 closing price
Capitalization
9.31B
27 days until earnings call
Intraday BUY SELL Signals
REPL
Price
$13.07
Change
-$0.38 (-2.83%)
Updated
Oct 2 closing price
Capitalization
1.18B
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs REPL

KYMR vs REPL Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. REPL commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and REPL is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
KYMR vs REPL: Fundamental Ratings
KYMR
REPL
OUTLOOK RATING
1..100
7215
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
50100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
4036
P/E GROWTH RATING
1..100
83100
SEASONALITY SCORE
1..100
9075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REPL's Valuation (54) in the Biotechnology industry is somewhat better than the same rating for KYMR (89) in the null industry. This means that REPL’s stock grew somewhat faster than KYMR’s over the last 12 months.

KYMR's Profit vs Risk Rating (50) in the null industry is somewhat better than the same rating for REPL (100) in the Biotechnology industry. This means that KYMR’s stock grew somewhat faster than REPL’s over the last 12 months.

KYMR's SMR Rating (95) in the null industry is in the same range as REPL (99) in the Biotechnology industry. This means that KYMR’s stock grew similarly to REPL’s over the last 12 months.

REPL's Price Growth Rating (36) in the Biotechnology industry is in the same range as KYMR (40) in the null industry. This means that REPL’s stock grew similarly to KYMR’s over the last 12 months.

KYMR's P/E Growth Rating (83) in the null industry is in the same range as REPL (100) in the Biotechnology industry. This means that KYMR’s stock grew similarly to REPL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KYMRREPL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (KYMR: $110.12 vs. REPL: $13.07)
Brand notoriety: KYMR and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 155% vs. REPL: 27%
Market capitalization -- KYMR: $9.31B vs. REPL: $1.18B
KYMR [@Biotechnology] is valued at $9.31B. REPL’s [@Biotechnology] market capitalization is $1.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green while REPL’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • REPL’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than REPL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 2 TA indicator(s) are bullish while REPL’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 2 bullish, 7 bearish.
  • REPL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, REPL is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а -4.91% price change this week, while REPL (@Biotechnology) price change was +5.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 29, 2026.

REPL is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
KYMR
Daily Signal:
Gain/Loss:
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
FUN.X0.0082750.000795
+10.63%
FUNToken cryptocurrency
PEPE.X0.000004N/A
+3.81%
Pepe cryptocurrency
BAR.X0.2844500.002941
+1.04%
FC Barcelona Fan Token cryptocurrency
ILV.X3.9143060.018051
+0.46%
Illuvium cryptocurrency
FRONT.X0.016364-0.000038
-0.23%
Frontier cryptocurrency

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with GPCR. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.49%
GPCR - KYMR
61%
Loosely correlated
-7.32%
NRIX - KYMR
58%
Loosely correlated
-1.56%
WVE - KYMR
51%
Loosely correlated
+4.86%
REPL - KYMR
44%
Loosely correlated
+1.59%
CGEM - KYMR
44%
Loosely correlated
-5.34%
More